FlowView Diagnostics

General Information

Company Name

Founded Year

2020

Location (Offices)

The Netherlands +1

Founders / Decision Makers

Number of Employees

Industries

Health Care, Information Technology

Funding Stage

Seed

Social Media

FlowView Diagnostics - Company Profile

FlowView Diagnostics is a pioneering company in the Health Care and Information Technology industries, specializing in AI-driven flow cytometry solutions. The company's mission is to reshape flow cytometry analysis through its innovative AI platform, Asudes. This cloud-based software aims to make complex data analysis accessible and actionable for healthcare professionals, researchers, and Clinical Research Organizations (CROs), providing automated flow cytometric identification of disease-specific cells using the patented Eclipse algorithm. Founded in 2020 and based in The Netherlands, FlowView Diagnostics recently received a €2.70M Seed Round investment on 24 June 2022 from Amatis, signifying a vote of confidence from the investor community in the company's potential to revolutionize flow cytometry analysis. The company's commitment to promoting consistency, enhancing data visualization capabilities, and automating procedures underscores its potential to provide healthcare professionals with the assurance and efficiency required for assessing complex medical parameters.

Taxonomy: AI-powered healthcare solutions, Flow cytometry data analysis, AI platform for healthcare professionals, Cloud-based software for medical data analysis, Disease-specific cell identification, Standardized protocols for medical data analysis, Automated medical data analysis, Healthcare data visualization, Clinical Research Organizations (CROs), Medical parameter assessment, Algorithm-driven medical diagnostics, Data analysis for researchers and clinicians, Cell data analysis, Precision healthcare analytics